Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Estriol
Drug ID BADD_D00829
Description A hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDA or Health Canada. It is however available in the United States by prescription filled only by compounding pharmacies. It has also been approved and marketed throughout Europe and Asia for approximately 40 years for the treatment of post-menopausal hot flashes.
Indications and Usage Estriol levels can be measured to give an indication of the general health of the fetus. DHEA-S is produced by the adrenal cortex of the fetus. This is converted to estriol by the placenta. If levels of "unconjugated estriol" are abnormally low in a pregnant woman, this may indicate a problem with the development of the child. The drug interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estriol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.
Marketing Status Not Available
ATC Code G03CA04; G03CC06
DrugBank ID DB04573
KEGG ID D00185
MeSH ID D004964
PubChem ID 5756
TTD Drug ID D0Z1FX
NDC Product Code 79572-017; 82653-002; 12860-0259; 44132-014; 44132-007; 49452-2794; 60722-0003; 71448-0001; 43647-234; 51552-1392; 76420-049; 60722-3004; 38779-0732; 73309-072; 60870-0259; 73377-070; 82018-0010; 82653-001
Synonyms Estriol | 16alpha,17beta-Estriol | 16alpha,17beta Estriol | (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol | 16-alpha-Hydroxy-Estradiol | 16 alpha Hydroxy Estradiol | Ovestin | Epiestriol | 16beta-Hydroxy-Estradiol | 16beta Hydroxy Estradiol | (16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol | Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol
Chemical Information
Molecular Formula C18H24O3
CAS Registry Number 50-27-1
SMILES CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site irritation12.07.01.003; 08.02.01.003--Not Available
Breast cancer21.05.01.003; 16.10.01.001--Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Cervical discharge21.06.01.001--Not Available
Chloasma23.05.01.001; 18.08.02.002--Not Available
Dementia19.20.02.001; 17.03.01.001--Not Available
Embolism venous24.01.01.003--Not Available
Endometrial cancer21.07.02.002; 16.12.02.001--Not Available
Erythema multiforme10.01.03.015; 23.03.01.003--
Erythema nodosum23.07.02.001; 10.02.01.020--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Gallbladder disorder09.03.02.001--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Myocardial infarction02.02.02.007; 24.04.04.009--
Nausea07.01.07.001--
Neoplasm16.16.02.001--Not Available
Pain08.01.08.004--
Pelvic venous thrombosis24.01.02.008--Not Available
Pruritus23.03.12.001--
Pulmonary embolism22.06.02.001; 24.01.06.001--Not Available
Vascular purpura23.06.01.008; 01.01.04.007; 24.07.06.011--Not Available
Breast discomfort21.05.05.007--Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Postmenopausal haemorrhage24.07.03.002; 21.02.01.002--Not Available
Breast disorder21.05.04.004--Not Available
Malnutrition14.03.02.004--Not Available
Invasive breast carcinoma21.05.01.013; 16.10.01.005--Not Available
The 1th Page    1    Total 1 Pages